PortfoliosLab logoPortfoliosLab logo
TMO vs. A
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

TMO vs. A - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Thermo Fisher Scientific Inc. (TMO) and Agilent Technologies, Inc. (A). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

TMO vs. A - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TMO
Thermo Fisher Scientific Inc.
-14.57%11.78%-1.72%-3.36%-17.29%43.54%43.72%45.55%18.21%35.03%
A
Agilent Technologies, Inc.
-15.48%1.92%-2.70%-6.42%-5.52%35.51%39.79%27.54%1.67%48.32%

Fundamentals

Market Cap

TMO:

$186.44B

A:

$32.53B

EPS

TMO:

$17.77

A:

$4.53

PE Ratio

TMO:

27.83

A:

25.26

PS Ratio

TMO:

4.19

A:

4.61

PB Ratio

TMO:

3.49

A:

4.71

Total Revenue (TTM)

TMO:

$44.56B

A:

$7.07B

Gross Profit (TTM)

TMO:

$18.02B

A:

$2.74B

EBITDA (TTM)

TMO:

$11.35B

A:

$1.72B

Returns By Period

In the year-to-date period, TMO achieves a -14.57% return, which is significantly higher than A's -15.48% return. Over the past 10 years, TMO has outperformed A with an annualized return of 13.56%, while A has yielded a comparatively lower 11.89% annualized return.


TMO

1D
0.61%
1M
-2.66%
YTD
-14.57%
6M
-6.66%
1Y
2.77%
3Y*
-4.68%
5Y*
1.90%
10Y*
13.56%

A

1D
0.49%
1M
-2.85%
YTD
-15.48%
6M
-17.01%
1Y
1.25%
3Y*
-5.33%
5Y*
-1.44%
10Y*
11.89%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMO vs. A — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMO
TMO Risk / Return Rank: 3939
Overall Rank
TMO Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
TMO Sortino Ratio Rank: 3838
Sortino Ratio Rank
TMO Omega Ratio Rank: 3737
Omega Ratio Rank
TMO Calmar Ratio Rank: 4040
Calmar Ratio Rank
TMO Martin Ratio Rank: 4040
Martin Ratio Rank

A
A Risk / Return Rank: 3838
Overall Rank
A Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
A Sortino Ratio Rank: 3535
Sortino Ratio Rank
A Omega Ratio Rank: 3535
Omega Ratio Rank
A Calmar Ratio Rank: 3939
Calmar Ratio Rank
A Martin Ratio Rank: 3939
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMO vs. A - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and Agilent Technologies, Inc. (A). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TMOADifference

Sharpe ratio

Return per unit of total volatility

0.09

0.04

+0.05

Sortino ratio

Return per unit of downside risk

0.38

0.29

+0.09

Omega ratio

Gain probability vs. loss probability

1.04

1.03

+0.01

Calmar ratio

Return relative to maximum drawdown

-0.01

-0.04

+0.03

Martin ratio

Return relative to average drawdown

-0.02

-0.09

+0.07

TMO vs. A - Sharpe Ratio Comparison

The current TMO Sharpe Ratio is 0.09, which is higher than the A Sharpe Ratio of 0.04. The chart below compares the historical Sharpe Ratios of TMO and A, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


TMOADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.09

0.04

+0.05

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.07

-0.05

+0.12

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.52

0.43

+0.09

Sharpe Ratio (All Time)

Calculated using the full available price history

0.41

0.14

+0.27

Correlation

The correlation between TMO and A is 0.58, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

TMO vs. A - Dividend Comparison

TMO's dividend yield for the trailing twelve months is around 0.36%, less than A's 0.88% yield.


TTM20252024202320222021202020192018201720162015
TMO
Thermo Fisher Scientific Inc.
0.36%0.30%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%
A
Agilent Technologies, Inc.
0.88%0.55%0.71%0.66%0.71%0.49%0.46%0.79%0.91%0.81%1.05%1.23%

Drawdowns

TMO vs. A - Drawdown Comparison

The maximum TMO drawdown since its inception was -71.16%, smaller than the maximum A drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for TMO and A.


Loading graphics...

Drawdown Indicators


TMOADifference

Max Drawdown

Largest peak-to-trough decline

-71.16%

-93.18%

+22.02%

Max Drawdown (1Y)

Largest decline over 1 year

-27.31%

-29.75%

+2.44%

Max Drawdown (5Y)

Largest decline over 5 years

-40.95%

-43.19%

+2.24%

Max Drawdown (10Y)

Largest decline over 10 years

-40.95%

-43.19%

+2.24%

Current Drawdown

Current decline from peak

-24.98%

-33.93%

+8.95%

Average Drawdown

Average peak-to-trough decline

-17.97%

-57.45%

+39.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.13%

11.50%

+0.63%

Volatility

TMO vs. A - Volatility Comparison

Thermo Fisher Scientific Inc. (TMO) has a higher volatility of 8.84% compared to Agilent Technologies, Inc. (A) at 7.15%. This indicates that TMO's price experiences larger fluctuations and is considered to be riskier than A based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


TMOADifference

Volatility (1M)

Calculated over the trailing 1-month period

8.84%

7.15%

+1.69%

Volatility (6M)

Calculated over the trailing 6-month period

19.06%

19.15%

-0.09%

Volatility (1Y)

Calculated over the trailing 1-year period

32.87%

31.81%

+1.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.59%

28.60%

-2.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.93%

27.44%

-1.51%

Financials

TMO vs. A - Financials Comparison

This section allows you to compare key financial metrics between Thermo Fisher Scientific Inc. and Agilent Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B202120222023202420252026
12.22B
1.80B
(TMO) Total Revenue
(A) Total Revenue
Values in USD except per share items

TMO vs. A - Profitability Comparison

The chart below illustrates the profitability comparison between Thermo Fisher Scientific Inc. and Agilent Technologies, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%60.0%202120222023202420252026
41.5%
0
Portfolio components
TMO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Thermo Fisher Scientific Inc. reported a gross profit of 5.07B and revenue of 12.22B. Therefore, the gross margin over that period was 41.5%.

A - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Agilent Technologies, Inc. reported a gross profit of 0.00 and revenue of 1.80B. Therefore, the gross margin over that period was 0.0%.

TMO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Thermo Fisher Scientific Inc. reported an operating income of 2.26B and revenue of 12.22B, resulting in an operating margin of 18.5%.

A - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Agilent Technologies, Inc. reported an operating income of 353.00M and revenue of 1.80B, resulting in an operating margin of 19.6%.

TMO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Thermo Fisher Scientific Inc. reported a net income of 1.97B and revenue of 12.22B, resulting in a net margin of 16.1%.

A - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Agilent Technologies, Inc. reported a net income of 305.00M and revenue of 1.80B, resulting in a net margin of 17.0%.